Biotech Values

[randychub]

"It seems that the predictive value of RR is now routinely discounted in “targeted” therapies such as Tarceva, but RR is still believed to be predictive of survival for cytotoxics. Perhaps this conventional wisdom needs to be updated."

Are you sure your not a biotech analyst for someone. The medical director, Paul Keane, told me just today that he was at a meeting with several biotech analysts recently and that was the common thought at this meeting.

Randy